Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
For 5-amino-1MQ specifically: Preclinical studies have not prominently described heart rate elevation as a dominant signal The mechanism (NNMT inhibition, NAD+ preservation) does not have the same direct cardiac implications as nuclear receptor agonism Human cardiovascular data at clinically relevant exposures are limited For physicians, the current evidence base does not support a major cardiovascular safety flag, but the limited human dataset means confident statements are premature
Many patients notice improvements in pain, inflammation, and mobility within 1-3 weeks of starting BPC/TB-5 therapy
They are not for human use or consumption
Scientific Background on BPC-157 (Body Protection Compound-157) BPC-157 is a stable synthetic pentadecapeptide derived from a protective protein in human gastric juice
US$ 20.24
US$ 20.02
US$ 23.55
US$ 27.53
US$ 28.20
US$ 26.32
